Global Montelukast Intermediate Market — Rest of Western Europe by Application
| Label | North America | United States | Canada |
|---|---|---|---|
| 2016 | 99.7 USD Mn | 77.1 USD Mn | 22.5 USD Mn |
| 2017 | 168.9 USD Mn | 131.1 USD Mn | 37.8 USD Mn |
| 2018 | 248.9 USD Mn | 193.7 USD Mn | 55.2 USD Mn |
| 2019 | 324 USD Mn | 252.6 USD Mn | 71.4 USD Mn |
| 2020 | 405.4 USD Mn | 316.4 USD Mn | 89.1 USD Mn |
| 2021 | 500.7 USD Mn | 389.8 USD Mn | 110.9 USD Mn |
| 2022 | 608.7 USD Mn | 470.8 USD Mn | 138 USD Mn |
| 2023 | 730.3 USD Mn | 559.3 USD Mn | 170.9 USD Mn |
| 2024 | 866 USD Mn | 653.9 USD Mn | 212.1 USD Mn |
Data Source: Wantstats Repository
Market Dynamics
United States accounted for the larger market share in 2018 in the North America nash biomarker market, and is expected to reach USD 653.90 Million in 2024 from USD 193.70 Million in 2018. However, Canada is the fastest growing market, which is expected to grow at a CAGR of 24.33% during the forecast period 2019 - 2024. Pharmaceutical Companies and CROs segment accounted for the largest market share in 2018, this market is expected to reach USD 337.70 Million in 2024 from USD 96.00 Million in 2018. This market is projected to grow at a CAGR of 22.09% during the forecast period from 2019 - 2024. Serum Biomarkers segment accounted for the largest market share in 2018, this market is expected to reach USD 318.30 Million in 2024 from USD 90.30 Million in 2018. This market is projected to grow at a CAGR of 21.95% during the forecast period from 2019 - 2024. However, Hepatic Fibrosis Biomarkers segment is the fastest growing market, which is expected to grow at a CAGR of 22.27% during the forecast period 2019 - 2024.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Related Charts
View AllPoland Lifetime risk of maternal death (1 in: rate varies by country)
Global Montelukast Intermediate Market — Eastern-Europe by Application
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



